Mr. Isaac Gilmore is a visionary leader driving transformative change in healthcare. As Chairman of Heroic Path to Light, Mr. Gilmore pioneers psychedelic-assisted therapy for veterans and first responders, embodying a commitment to holistic healing. His role as an Advisory Council Member for Concordia Summit underscores his dedication to shaping global healthcare policies. Isaac’s tenure as Chief Growth Officer at TREAT California, where he spearheaded a groundbreaking $5 billion initiative in psychedelic therapy, exemplifies his forward-thinking approach. With a diverse background spanning defense, finance, and entrepreneurship, Isaac brings a unique perspective to NuMind Health, fostering innovation and pushing boundaries. His strategic partnerships and coalitions within the psychedelic community amplify NuMind’s mission, positioning the company at the forefront of healthcare innovation. With Isaac’s leadership, NuMind Health is poised to revolutionize mental health treatment, offering hope and healing to individuals worldwide while championing collaboration and progress across sectors for the betterment of all.